Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cerus Corp (CERS)

Cerus Corp (CERS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 338,349
  • Shares Outstanding, K 184,890
  • Annual Sales, $ 186,800 K
  • Annual Income, $ -37,490 K
  • 60-Month Beta 1.19
  • Price/Sales 2.11
  • Price/Cash Flow N/A
  • Price/Book 7.26
Trade CERS with:

Options Overview Details

View History
  • Implied Volatility 253.38% ( +57.53%)
  • Historical Volatility 66.16%
  • IV Percentile 98%
  • IV Rank 58.57%
  • IV High 422.79% on 10/06/23
  • IV Low 13.90% on 07/08/24
  • Put/Call Vol Ratio 0.06
  • Today's Volume 54
  • Volume Avg (30-Day) 99
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 4,532
  • Open Int (30-Day) 4,574

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -0.03
  • Number of Estimates 1
  • High Estimate -0.03
  • Low Estimate -0.03
  • Prior Year -0.03
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.7800 +1.12%
on 09/20/24
2.3900 -24.69%
on 08/27/24
-0.3800 (-17.43%)
since 08/20/24
3-Month
1.6450 +9.42%
on 07/05/24
2.5400 -29.13%
on 08/02/24
+0.1100 (+6.51%)
since 06/20/24
52-Week
1.2050 +49.38%
on 10/09/23
2.5850 -30.37%
on 03/07/24
+0.2500 (+16.13%)
since 09/20/23

Most Recent Stories

More News
Cerus: Q2 Earnings Snapshot

Cerus: Q2 Earnings Snapshot

CERS : 1.8000 (-1.64%)
Cerus: Q1 Earnings Snapshot

Cerus: Q1 Earnings Snapshot

CERS : 1.8000 (-1.64%)
Cerus: Q4 Earnings Snapshot

Cerus: Q4 Earnings Snapshot

CERS : 1.8000 (-1.64%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The widely followed growth investor keeps making moves.

^BTCUSD : 63,111.07 (+0.42%)
^BTCUSDT : 63,098.42 (+0.43%)
TSLA : 238.25 (-2.32%)
ARKB : 62.77 (-0.70%)
CERS : 1.8000 (-1.64%)
3 Growth Stocks That Could Go Parabolic in 2024

These innovation-oriented companies could take flight this year.

ABCL : 2.59 (-5.47%)
CERS : 1.8000 (-1.64%)
TSHA : 2.15 (-1.83%)
Cerus: Q3 Earnings Snapshot

Cerus: Q3 Earnings Snapshot

CERS : 1.8000 (-1.64%)
Cerus: Q2 Earnings Snapshot

Cerus: Q2 Earnings Snapshot

CERS : 1.8000 (-1.64%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The widely followed growth investor keeps making moves.

COIN : 170.09 (+1.10%)
RKLB : 7.47 (+4.18%)
CERS : 1.8000 (-1.64%)
Cerus: Q1 Earnings Snapshot

Cerus: Q1 Earnings Snapshot

CERS : 1.8000 (-1.64%)
Cerus Corporation Announces First Quarter 2023 Financial Results

Cerus Corporation (Nasdaq: CERS) today announced financial results for the first quarter ended March 31, 2023.

CERS : 1.8000 (-1.64%)

Business Summary

Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company...

See More

Key Turning Points

3rd Resistance Point 1.8850
2nd Resistance Point 1.8600
1st Resistance Point 1.8300
Last Price 1.8000
1st Support Level 1.7750
2nd Support Level 1.7500
3rd Support Level 1.7200

See More

52-Week High 2.5850
Fibonacci 61.8% 2.0578
Fibonacci 50% 1.8950
Last Price 1.8000
Fibonacci 38.2% 1.7322
52-Week Low 1.2050

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar